Efficacy, Safety And Feasibility Of Antiemetic Prophylaxis With Fosaprepitant, Granisetron And Dexamethasone In Pediatric Patients With Hemato-Oncological Malignancies

BACKGROUND: Chemotherapy-induced nausea and vomiting (CINV) are a major burden for patients undergoing emetogenic chemotherapy. International guidelines recommend an antiemetic prophylaxis with corticosteroids, 5-HT(3)R-antagonists and NK(1)R-antagonists. The NK(1)R-antagonist fosaprepitant has show...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Drug Des Devel Ther
Autors principals: Cabanillas Stanchi, Karin Melanie, Ebinger, Martin, Hartmann, Ulrike, Queudeville, Manon, Feucht, Judith, Ost, Michael, Koch, Marie-Sarah, Malaval, Carmen, Mezger, Markus, Schober, Sarah, Weber, Simone, Michaelis, Sebastian, Lange, Veit, Lang, Peter, Handgretinger, Rupert, Döring, Michaela
Format: Artigo
Idioma:Inglês
Publicat: Dove 2019
Matèries:
Original Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6777642/
https://ncbi.nlm.nih.gov/pubmed/31686784
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/DDDT.S214264
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars